Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
Ischemia-reperfusion (I/R) is a pathological process that occurs in many organs and diseases. Reperfusion, recovery of blood flow, and reoxygenation often lead to reperfusion injury. Drug therapy and early reperfusion therapy can reduce tissue injury and cell necrosis caused by ischemia, leading to...
Enregistré dans:
Auteurs principaux: | Xinye Li, Ning Ma, Juping Xu, Yanchi Zhang, Pan Yang, Xin Su, Yanfeng Xing, Na An, Fan Yang, Guoxia Zhang, Lijing Zhang, Yanwei Xing |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Hindawi Limited
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f913e1ed6d1e4623b47ba4e986f43a48 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
par: Yani Wang, et autres
Publié: (2021) -
Ubiquitin-Specific Protease 29 Exacerbates Cerebral Ischemia-Reperfusion Injury in Mice
par: Jia-Bao Hou, et autres
Publié: (2021) -
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
par: Weihua Gao, et autres
Publié: (2021) -
Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation
par: Qiang Xie, et autres
Publié: (2021) -
Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis
par: Dingyi Lv, et autres
Publié: (2021)